Compile Data Set for Download or QSAR
maximum 50k data
Found 348 of ph data with Target = 'Lysosomal protective protein [29-480]'
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183942(US9150526, 205)
Affinity DataIC50:  2nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183959(US9150526, 222)
Affinity DataIC50:  4nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183758(US9150526, 7)
Affinity DataIC50:  5nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183901(US9150526, 154)
Affinity DataIC50:  5nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183943(US9150526, 206)
Affinity DataIC50:  6nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183761(US9150526, 10)
Affinity DataIC50:  7nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183949(US9150526, 212)
Affinity DataIC50:  8nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183902(US9150526, 155)
Affinity DataIC50:  8nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183944(US9150526, 207)
Affinity DataIC50:  10nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183918(US9150526, 176)
Affinity DataIC50:  10nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183801(US9150526, 51)
Affinity DataIC50:  11nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183955(US9150526, 218)
Affinity DataIC50:  12nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183954(US9150526, 217)
Affinity DataIC50:  13nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183938(US9150526, 201)
Affinity DataIC50:  14nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183947(US9150526, 210)
Affinity DataIC50:  14nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183843(US9150526, 96)
Affinity DataIC50:  14nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183818(US9150526, 71)
Affinity DataIC50:  16nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183844(US9150526, 97)
Affinity DataIC50:  16nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183951(US9150526, 214)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183946(US9150526, 209)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183940(US9150526, 203)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183939(US9150526, 202)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183912(US9150526, 169)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183904(US9150526, 157)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183882(US9150526, 135)
Affinity DataIC50:  17nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183820(US9150526, 73)
Affinity DataIC50:  18nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183819(US9150526, 72)
Affinity DataIC50:  18nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183845(US9150526, 98)
Affinity DataIC50:  18nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183821(US9150526, 74)
Affinity DataIC50:  19nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183822(US9150526, 75)
Affinity DataIC50:  21nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183958(US9150526, 221)
Affinity DataIC50:  22nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183948(US9150526, 211)
Affinity DataIC50:  23nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183919(US9150526, 177)
Affinity DataIC50:  24nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183884(US9150526, 137)
Affinity DataIC50:  24nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183883(US9150526, 136)
Affinity DataIC50:  24nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183900(US9150526, 153)
Affinity DataIC50:  25nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183927(US9150526, 185)
Affinity DataIC50:  27nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183846(US9150526, 99)
Affinity DataIC50:  28nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183823(US9150526, 76)
Affinity DataIC50:  28nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183824(US9150526, 77)
Affinity DataIC50:  29nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183770(US9150526, 20)
Affinity DataIC50:  30nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183941(US9150526, 204)
Affinity DataIC50:  31nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183915(US9150526, 172)
Affinity DataIC50:  33nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183759(US9150526, 8)
Affinity DataIC50:  34nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183937(US9150526, 200)
Affinity DataIC50:  35nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183756(US9150526, 5)
Affinity DataIC50:  35nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183825(US9150526, 78)
Affinity DataIC50:  37nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183826(US9150526, 79)
Affinity DataIC50:  38nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183885(US9150526, 138)
Affinity DataIC50:  41nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetLysosomal protective protein [29-480](Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM183765(US9150526, 15)
Affinity DataIC50:  44nMpH: 6.0 T: 2°CAssay Description:Recombinant human cathepsin A (residues 29-480, with a C-terminal 10-His tag; R&D Systems, #1049-SE) was proteolytically activated with recombinant h...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 348 total ) | Next | Last >>
Jump to: